Roughly one in ten pregnancies involves elevated glucose — and most women feel completely normal while it happens. Here is what the numbers mean, how screening works, and what actually lowers risk for both mother and baby.
High blood sugar during pregnancy most often means gestational diabetes, which affects roughly 2% to 10% of U.S. pregnancies each year.[1] It is usually diagnosed between 24 and 28 weeks with a glucose tolerance test, and the ADA targets are fasting under 95 mg/dL, 1-hour post-meal under 140 mg/dL, and 2-hour post-meal under 120 mg/dL.[2] Diet, activity, glucose monitoring, and insulin when needed keep the vast majority of pregnancies safe.
- What high blood sugar in pregnancy actually means
- Why glucose rises: the placental physiology
- Risk factors and who needs early screening
- Symptoms — and why most women feel nothing
- How it is diagnosed: the exact numbers
- Treatment targets and the stepwise approach
- Diet and activity changes that move the needle
- Complications for mother and baby
- After delivery: the test too many women miss
- When to call your doctor
- Frequently asked questions
What High Blood Sugar During Pregnancy Actually Means
"High blood sugar during pregnancy" is an umbrella phrase covering two clinically distinct situations, and the difference matters enormously for how a pregnancy is managed.
The first is pre-existing diabetes — type 1 or type 2 diabetes that was present before conception. This is the higher-stakes scenario, because glucose is already elevated during the first trimester, when the fetal organs are forming. Poorly controlled pre-gestational diabetes is associated with a higher rate of congenital heart and neural tube defects, which is why the ADA recommends an A1C below 6.5% before conception where achievable and a first-trimester A1C target of under 6% in most pregnancies.[2]
The second, far more common situation is gestational diabetes mellitus (GDM) — glucose intolerance that is first recognized during pregnancy, typically in the second or third trimester. Because the fetal structural development window has already closed by the time GDM appears, it does not carry the same malformation risk. Its risks are instead about fetal growth, delivery, and the newborn's transition after birth.
A third category sits in between: overt diabetes diagnosed in pregnancy, where a woman's first prenatal labs show glucose values in the diabetic range (A1C ≥6.5%, fasting ≥126 mg/dL, or 2-hour value ≥200 mg/dL on an oral glucose tolerance test). The ADA treats this as pre-existing diabetes that simply had not been detected before, not as gestational diabetes.[2]
Pre-gestational diabetes is present at conception and affects organ formation; gestational diabetes emerges mid-pregnancy and affects fetal growth, birth weight, and neonatal glucose stability.
Why Blood Sugar Rises: The Placental Physiology Nobody Explains
Pregnancy is, by design, a state of progressive insulin resistance. A healthy pancreas compensates by ramping up insulin output by two- to three-fold. Gestational diabetes appears when that compensation falls short.
The driver is the placenta. As it grows through the second and third trimesters, it secretes human placental lactogen (also called human chorionic somatomammotropin) in increasing quantities, along with placental growth hormone, progesterone, cortisol, and pro-inflammatory cytokines. These hormones blunt insulin's ability to move glucose into muscle and fat. By the third trimester, maternal insulin sensitivity can fall by 40% to 70% compared with pre-pregnancy.
There is an evolutionary logic to this. The resistance deliberately redirects glucose across the placenta to the fetus, which needs a steady fuel supply. In a woman whose beta cells can keep pace, blood sugar stays in the normal range despite the resistance. In a woman whose beta cells cannot — because of underlying beta-cell dysfunction, pre-existing insulin resistance, or simply limited reserve — glucose climbs into the diabetic range.
This timing explains why screening happens when it does. Insulin resistance is relatively mild at 16 weeks and peaks around 32 to 36 weeks. Testing between 24 and 28 weeks hits the window where the physiology is established but there is still time to intervene before the period of most rapid fetal growth.
Gestational diabetes is not a disease the mother "caught" during pregnancy — it is a stress test of the pancreas that pregnancy performs, and roughly one in ten women does not pass it.
GlycoBeacon editorial review
Who Is at Higher Risk — and Why Universal Screening Still Matters
Certain characteristics raise the pre-test probability of gestational diabetes enough that the ADA and ACOG support screening at the first prenatal visit rather than waiting until 24 to 28 weeks. But here is the wrinkle that shapes modern practice: roughly half of women who develop GDM have no traditional risk factors at all, which is why nearly every pregnant woman is screened regardless.
The risk factors below are the ones that trigger early testing rather than routine-timing testing. Tap each to see the mechanism behind it.
Obesity or overweight before pregnancy
Pre-pregnancy BMI of 25 or above — and especially 30 or above — is the single strongest modifiable risk factor. Excess adipose tissue is already insulin resistant before the placenta adds its own contribution, so the beta cell begins pregnancy behind on compensation.
Previous pregnancy with gestational diabetes
Recurrence risk is high — commonly cited in the range of 30% to 70% depending on the population. A prior GDM pregnancy effectively documents that the beta cell has limited reserve under metabolic stress, so early screening in the next pregnancy is standard.
Prior baby weighing more than 9 pounds (4 kg)
Macrosomia in a previous pregnancy is a retrospective marker of undiagnosed glucose intolerance. It suggests the prior pregnancy carried unrecognized hyperglycemia and should lower the threshold for early testing this time.
Family history of diabetes in a first-degree relative
A parent or sibling with type 2 diabetes signals inherited beta-cell vulnerability. This is one of the strongest non-modifiable predictors and appears in essentially every validated GDM risk model.
Polycystic ovary syndrome (PCOS)
PCOS is characterized by baseline insulin resistance and compensatory hyperinsulinemia. Women with PCOS enter pregnancy with a pancreas already working harder than normal, leaving less headroom when placental hormones are added.
Age 25 or older — with risk rising steadily past 35
Maternal age is an independent risk factor. Beta-cell function declines gradually with age, and older mothers have had more cumulative exposure to metabolic stressors. Many practices now use 25 as the threshold for offering early screening.
Certain racial and ethnic backgrounds
Higher rates of GDM are documented among Black, Hispanic/Latina, Native American, Alaska Native, Asian American, and Pacific Islander women. These differences reflect a mix of genetic predisposition, structural barriers to care, and differences in body composition at the same BMI — not biology in isolation.
Chronic hypertension, prediabetes, or previous cardiovascular disease
These conditions cluster with insulin resistance and endothelial dysfunction. A history of prediabetes (A1C 5.7%–6.4%) in particular suggests the beta cell is already under strain and warrants an early A1C in pregnancy.
Medications that raise glucose
Glucocorticoids, some antipsychotics, and certain immunosuppressants can push glucose upward. If you take one of these, tell your obstetric team early so screening is timed appropriately.
Symptoms — and Why Most Women Feel Completely Normal
Here is the fact that surprises most patients: the majority of women with gestational diabetes have no symptoms whatsoever. The classic trio of increased thirst, frequent urination, and fatigue is unreliable in pregnancy, because all three are normal pregnancy experiences caused by increased blood volume, pressure on the bladder, and rising progesterone.
When symptoms do occur, they tend to appear only with more marked hyperglycemia and may include:
- Excessive thirst that persists despite drinking
- Urinating far more often than the typical pregnancy pattern, especially waking repeatedly at night
- Blurred vision that fluctuates through the day
- Recurrent yeast infections or urinary tract infections
- Unexplained fatigue beyond usual pregnancy tiredness
- Rapid weight gain or a fetus measuring large for gestational age on ultrasound
Because symptoms are so unreliable, screening is universal. Do not use the absence of symptoms as reassurance — and do not use their presence as a diagnosis.
Symptoms that are emergencies, not waiting-room questions
How Gestational Diabetes Is Diagnosed: The Exact Numbers
Screening for gestational diabetes happens at 24 to 28 weeks in women without early risk factors, a timing endorsed by both the ADA and the U.S. Preventive Services Task Force, which gives screening a Grade B recommendation.[2][4] Practices use one of two strategies, and both are considered acceptable.
| Strategy | Step 1 | Step 2 | Diagnostic thresholds |
|---|---|---|---|
| One-step (75-g OGTT) | Fasting 75-g oral glucose tolerance test | None — single test | Fasting ≥92, 1-hour ≥180, 2-hour ≥153 mg/dL. One abnormal value diagnoses GDM. |
| Two-step (most common in the U.S.) | 50-g glucose challenge, non-fasting, any time of day | If 1-hour value ≥130–140 mg/dL, proceed to 100-g, 3-hour OGTT | Carpenter–Coustan: fasting ≥95, 1-hour ≥180, 2-hour ≥155, 3-hour ≥140 mg/dL. Two or more abnormal values diagnose GDM. |
| Early screening (first prenatal visit) | A1C or fasting glucose for women with risk factors | Standard OGTT if abnormal | A1C ≥6.5%, fasting ≥126 mg/dL, or 2-hour ≥200 mg/dL indicates overt diabetes, not GDM. |
Once diagnosed, most women are asked to check blood glucose four times daily — fasting and one or two hours after each of three meals. The ADA's targets for pregnancy are tighter than targets for non-pregnant adults with diabetes.[2]
| Measurement | ADA pregnancy target |
|---|---|
| Fasting glucose | <95 mg/dL |
| 1-hour postprandial | <140 mg/dL |
| 2-hour postprandial | <120 mg/dL |
| A1C | <6% (if achievable without hypoglycemia) |
Treatment: A Stepwise Approach, Starting With Food and Movement
Between 70% and 85% of women with gestational diabetes reach target glucose with nutrition therapy, activity, and structured self-monitoring alone. The remainder need medication, and insulin is the preferred first-line agent.
Severely restricting carbohydrates can produce ketosis and inadequate fetal fuel, and it often backfires by driving rebound glucose variability. The goal is distribution and quality — spreading carbohydrate evenly across the day and choosing low-glycemic sources — not elimination. Guidance from a dietitian is what separates these two approaches.
Diet and Activity Changes That Actually Move the Numbers
Effective nutrition therapy for gestational diabetes follows a few high-yield principles. None of them require eliminating entire food groups or eating differently from the rest of the family.
A week of readings where the fasting values sit consistently between 80 and 92 mg/dL, post-meal values peak around 120 to 130 and return toward baseline by two hours, and you are eating enough to gain weight within your recommended range without ketones. Stable, unremarkable numbers are the goal — not the lowest possible numbers.
Complications for Mother and Baby — and What Treatment Actually Prevents
Untreated hyperglycemia in pregnancy creates a two-sided problem: the mother's glucose crosses the placenta freely, but her insulin does not. The fetus responds by producing its own insulin in large quantities, and fetal insulin is a growth hormone.
The result is fetal hyperinsulinemia, which drives excess fat and protein deposition and produces a larger-than-normal baby. That single mechanism cascades into most of the delivery-related complications associated with GDM.
Risks to the baby
- Macrosomia — birth weight above about 4,000–4,500 g, which raises the risk of shoulder dystocia (the shoulders catching behind the pubic bone) and birth injury
- Neonatal hypoglycemia — the baby's insulin production stays high after the maternal glucose supply is cut at birth, dropping blood sugar in the first hours; this is monitored closely and usually resolves with early feeding
- Jaundice and respiratory problems — both occur at higher rates in infants of mothers with GDM
- Higher rate of cesarean delivery and of admission to the neonatal intensive care unit
- Longer-term risk of childhood obesity and impaired glucose tolerance, which is why follow-up of these children matters
Risks to the mother
- Preeclampsia — gestational diabetes roughly doubles the risk, which is why blood pressure monitoring continues throughout pregnancy
- Polyhydramnios — excess amniotic fluid from fetal polyuria
- Higher cesarean rate and higher risk of operative vaginal delivery
- Type 2 diabetes later in life — approximately half of women with gestational diabetes develop type 2 diabetes within 5 to 10 years of delivery[1]
Treatment works. The landmark randomized trials behind modern GDM management showed that treating mild gestational diabetes reduced macrosomia, shoulder dystocia, and preeclampsia compared with no treatment. The complications above are risks of untreated hyperglycemia — not an inevitable outcome of the diagnosis.
After Delivery: The 4–12 Week Test That Too Many Women Miss
Gestational diabetes usually resolves within hours of delivery, when the placenta — the source of the insulin resistance — is delivered. But the underlying beta-cell vulnerability does not disappear with it, and that is the part that shapes the next several decades of a woman's health.
Both the ADA and ACOG recommend a 75-g oral glucose tolerance test at 4 to 12 weeks postpartum for everyone diagnosed with GDM.[2][3] Attendance at this test is notoriously low — it typically falls somewhere between roughly a third and a half of eligible women in U.S. cohorts. Skipping it means missing the window to identify women who have already crossed into prediabetes or type 2 diabetes.
After that postpartum test:
Breastfeeding is worth prioritizing for reasons that go beyond infant nutrition: lactation is associated with improved maternal insulin sensitivity and a lower subsequent risk of type 2 diabetes in women with prior GDM.
And if another pregnancy is planned, arrange a preconception visit. Starting a pregnancy with an A1C in the normal range, rather than discovering hyperglycemia mid-pregnancy, changes the entire risk profile.
When to Call Your Doctor
Contact your obstetric or diabetes care team promptly — the same day, not at your next scheduled visit — if any of the following applies.
Frequently Asked Questions
Does gestational diabetes mean my baby will definitely have problems?
No. Most women who reach their glucose targets deliver healthy babies without complications. The elevated risk figures in the medical literature largely reflect untreated or poorly controlled hyperglycemia. Reaching the ADA targets — fasting under 95 mg/dL and post-meal values under 140 (1-hour) or 120 (2-hour) — substantially reduces the risk of macrosomia and preeclampsia.
Will I need a cesarean delivery because of gestational diabetes?
Not necessarily, and not automatically. Cesarean rates are higher among women with GDM, largely driven by larger estimated fetal weight and by induction that does not progress. If your baby's estimated weight is in a normal range and glucose is well controlled, a vaginal delivery is entirely reasonable. The decision should be based on fetal size, position, your obstetric history, and how labor progresses — not on the diagnosis alone.
Does gestational diabetes go away after birth?
The glucose elevation itself typically resolves within hours to days of delivery, because the placenta — the source of the insulin resistance — is gone. But a history of GDM means roughly a 50% chance of developing type 2 diabetes within 5 to 10 years.[1] That is why the postpartum 75-g oral glucose tolerance test at 4 to 12 weeks and lifelong screening every 1 to 3 years are both essential.
Can I prevent gestational diabetes?
You cannot fully prevent it, because placental hormone production is not something you control. But you can lower the odds meaningfully: entering pregnancy at a healthy weight, staying active before and during pregnancy, and eating a high-fiber diet with minimal sugar-sweetened beverages are all associated with lower risk. If you have a prior history of GDM, a preconception visit with an A1C check is the highest-yield single step.
Is insulin safe for my baby?
Yes. Insulin is a large molecule that does not cross the placenta, and it has the longest safety record of any glucose-lowering medication in pregnancy. It is the ADA-preferred first-line pharmacologic treatment for gestational diabetes when lifestyle measures are insufficient.[2]
Do I still need to check my blood sugar if I feel fine?
Yes — and this is the most common point of confusion. Gestational diabetes is usually asymptomatic, so how you feel tells you almost nothing about your glucose. The readings are what guide treatment. Women who stop monitoring because they feel well are precisely the ones who miss the escalation in insulin resistance that occurs between 28 and 36 weeks.
What is the difference between gestational diabetes and "borderline" high blood sugar in pregnancy?
There is no separate clinical category called borderline gestational diabetes — the diagnostic thresholds are binary. What people usually mean is a screening test that was elevated but a diagnostic test that did not meet criteria, or glucose values that sit just inside the normal range. In those cases, providers often recommend earlier repeat testing or closer monitoring, since glucose tends to rise as pregnancy progresses.
- Gestational diabetes affects roughly 2% to 10% of U.S. pregnancies each year and usually produces no symptoms at all.[1]
- Standard screening happens at 24 to 28 weeks; women with risk factors should be screened at their first prenatal visit instead.
- ADA pregnancy glucose targets are fasting <95 mg/dL, 1-hour post-meal <140 mg/dL, and 2-hour post-meal <120 mg/dL, with an A1C goal under 6%.[2]
- Most women reach target with nutrition therapy, post-meal walking, and glucose monitoring; insulin is the preferred medication when needed and does not cross the placenta.
- The main complications — macrosomia, shoulder dystocia, neonatal hypoglycemia, and preeclampsia — are risks of untreated hyperglycemia and are substantially reduced with treatment.
- A 75-g oral glucose tolerance test at 4 to 12 weeks postpartum is mandatory, followed by lifelong screening every 1 to 3 years, because about half of women with GDM develop type 2 diabetes within 5 to 10 years.[1][3]
- Centers for Disease Control and Prevention. Gestational Diabetes and National Diabetes Statistics Report. U.S. Department of Health and Human Services. cdc.gov
- American Diabetes Association. Standards of Care in Diabetes—2026: Management of Diabetes in Pregnancy. Diabetes Care, 2026. diabetes.org
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 190: Gestational Diabetes Mellitus. acog.org
- U.S. Preventive Services Task Force. Screening for Gestational Diabetes Mellitus: Recommendation Statement. uspreventiveservicestaskforce.org
- National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program (DPP) Outcomes. National Institutes of Health. niddk.nih.gov
